Sonoma Pharmaceuticals Ownership 2024 | Who Owns Sonoma Pharmaceuticals Now?


OverviewRevenueFinancialsChart

Institutional Ownership

2.79%

Insider Ownership

1.51%

Retail Ownership

95.70%

Institutional Holders

17.00

Sonoma Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GEODE CAPITAL MANAGEMENT, LLC0.56%-86,64450,864142.16%18,385Jun 30, 2024
STATE STREET CORP0.16%-24,315--5,160,000Jun 30, 2024
HRT FINANCIAL LP0.14%-21,51921,519100.00%4,000Jun 30, 2024
XTX TOPCO LTD0.13%0.00%19,8343,37120.48%4,209Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.10%-15,3251,85213.75%3,252Jun 30, 2024
UBS GROUP AG0.08%-11,91711,81411469.90%2,527Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.05%-8,268-3,712-30.98%1,753Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.02%-3,4003,400100.00%722Jun 30, 2024
BLACKROCK INC.0.01%-2,266--481Jun 30, 2024
US BANCORP \DE\0.00%-500--106Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-200200100.00%42Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-172128290.91%36Jun 30, 2024
MORGAN STANLEY0.00%-86--18Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-65--21Jun 30, 2024
WELLS FARGO & COMPANY/MN0.00%-33-89-72.95%7Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----13,016-100.00%-Jun 30, 2024

Sonoma Pharmaceuticals's largest institutional shareholder is GEODE CAPITAL MANAGEMENT, LLC, holding 0.56% of the company's total share outstanding, currently valued at $18.39K. The top 10 institutional shareholders own together 1.24% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
XTX TOPCO LTD0.13%0.00%19,8343,37120.48%4,209Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.10%-15,3251,85213.75%3,252Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.05%-8,268-3,712-30.98%1,753Jun 30, 2024
HRT FINANCIAL LP0.14%-21,51921,519100.00%4,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.56%-86,64450,864142.16%18,385Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.02%-3,4003,400100.00%722Jun 30, 2024
UBS GROUP AG0.08%-11,91711,81411469.90%2,527Jun 30, 2024
STATE STREET CORP0.16%-24,315--5,160,000Jun 30, 2024
US BANCORP \DE\0.00%-500--106Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-65--21Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-200200100.00%42Jun 30, 2024
BLACKROCK INC.0.01%-2,266--481Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-172128290.91%36Jun 30, 2024
WELLS FARGO & COMPANY/MN0.00%-33-89-72.95%7Jun 30, 2024
MORGAN STANLEY0.00%-86--18Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----13,016-100.00%-Jun 30, 2024

The largest Sonoma Pharmaceuticals shareholder by % of total assets is XTX TOPCO LTD. The company owns 19.83K shares of Sonoma Pharmaceuticals (SNOA), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GEODE CAPITAL MANAGEMENT, LLC0.56%-86,64450,864142.16%18,385Jun 30, 2024
HRT FINANCIAL LP0.14%-21,51921,519100.00%4,000Jun 30, 2024
UBS GROUP AG0.08%-11,91711,81411469.90%2,527Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.02%-3,4003,400100.00%722Jun 30, 2024
XTX TOPCO LTD0.13%0.00%19,8343,37120.48%4,209Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.10%-15,3251,85213.75%3,252Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-200200100.00%42Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-172128290.91%36Jun 30, 2024
MORGAN STANLEY0.00%-86--18Jun 30, 2024
BLACKROCK INC.0.01%-2,266--481Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-65--21Jun 30, 2024
US BANCORP \DE\0.00%-500--106Jun 30, 2024
STATE STREET CORP0.16%-24,315--5,160,000Jun 30, 2024
WELLS FARGO & COMPANY/MN0.00%-33-89-72.95%7Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.05%-8,268-3,712-30.98%1,753Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----13,016-100.00%-Jun 30, 2024

As of Jun 30 2024, Sonoma Pharmaceuticals's largest institutional buyer is GEODE CAPITAL MANAGEMENT, LLC. The company purchased 50.86K stocks of SNOA, valued at $18.39K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC----13,016-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.05%-8,268-3,712-30.98%1,753Jun 30, 2024
WELLS FARGO & COMPANY/MN0.00%-33-89-72.95%7Jun 30, 2024
STATE STREET CORP0.16%-24,315--5,160,000Jun 30, 2024
US BANCORP \DE\0.00%-500--106Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-65--21Jun 30, 2024
BLACKROCK INC.0.01%-2,266--481Jun 30, 2024
MORGAN STANLEY0.00%-86--18Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-172128290.91%36Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-200200100.00%42Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.10%-15,3251,85213.75%3,252Jun 30, 2024
XTX TOPCO LTD0.13%0.00%19,8343,37120.48%4,209Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.02%-3,4003,400100.00%722Jun 30, 2024
UBS GROUP AG0.08%-11,91711,81411469.90%2,527Jun 30, 2024
HRT FINANCIAL LP0.14%-21,51921,519100.00%4,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.56%-86,64450,864142.16%18,385Jun 30, 2024

As of Jun 30 2024, Sonoma Pharmaceuticals's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -13.02K shares of SNOA, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
QUBE RESEARCH & TECHNOLOGIES LTD0.02%-3,4003,400100.00%722Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-200200100.00%42Jun 30, 2024

Sonoma Pharmaceuticals's largest new institutional shareholder by number of shares is QUBE RESEARCH & TECHNOLOGIES LTD, purchased 3.40K shares, valued at $722.00, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC----13,016-100.00%-Jun 30, 2024

Sonoma Pharmaceuticals's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -13.02K shares, valued at -, as of undefined.

Sonoma Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BRIDGEWAY FUNDS INC0.00%6,600--Mar 28, 2024
HUSSMAN INVESTMENT TRUST0.00%3,100--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%35,780--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%3,818-3,818-50.00%Mar 31, 2024
Dimensional ETF Trust0.00%1,648--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%3,110--Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%439--Jan 31, 2024

Sonoma Pharmaceuticals's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 6.60K shares, compromising 0.00% of its total assets.

Sonoma Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 241721.43%
31 Mar, 2414-12.50%
31 Dec, 231633.33%
30 Sep, 2312-20.00%
30 Jun, 2315-11.76%
31 Mar, 231730.77%
31 Dec, 221344.44%
30 Sep, 229-10.00%
30 Jun, 2210-
31 Mar, 2210-9.09%
31 Dec, 2111-8.33%
30 Sep, 2112-7.69%
30 Jun, 21138.33%
31 Mar, 2112-
31 Dec, 2012-7.69%
30 Sep, 201362.50%
30 Jun, 208-11.11%
31 Mar, 209-10.00%
31 Dec, 191011.11%
30 Sep, 199-10.00%
30 Jun, 1910-

As of 30 Jun 24, 17 institutions are holding Sonoma Pharmaceuticals's shares, representing an increase of 21.43% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 24434,996164.81%
31 Mar, 24164,265-45.93%
31 Dec, 23303,776141.45%
30 Sep, 23125,814-22.31%
30 Jun, 23161,94510.38%
31 Mar, 23146,7153.00%
31 Dec, 22142,440-20.26%
30 Sep, 22178,621-3.28%
30 Jun, 22184,6807.41%
31 Mar, 22171,945-3.02%
31 Dec, 21177,299-16.57%
30 Sep, 21212,5040.20%
30 Jun, 21212,09019.76%
31 Mar, 21177,098-2.21%
31 Dec, 20181,097-7.65%
30 Sep, 20196,10538.69%
30 Jun, 20141,39610.47%
31 Mar, 20127,9970.16%
31 Dec, 19127,78861.66%
30 Sep, 1979,047-0.92%
30 Jun, 1979,785-

Sonoma Pharmaceuticals (SNOA) has 435.00K shares outstanding as of 30 Jun 24, up 164.81% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 242.79%122.92%
31 Mar, 241.51%19.42%
31 Dec, 232.78%42.86%
30 Sep, 232.55%11.20%
30 Jun, 234.77%21.40%
31 Mar, 234.72%22.47%
31 Dec, 224.58%13.82%
30 Sep, 225.76%16.24%
30 Jun, 225.96%14.18%
31 Mar, 226.48%19.56%
31 Dec, 215.76%7.00%
30 Sep, 219.07%8.83%
30 Jun, 2110.13%12.87%
31 Mar, 218.87%11.39%
31 Dec, 208.83%9.25%
30 Sep, 209.77%16.52%
30 Jun, 207.69%15.87%
31 Mar, 206.96%9.59%
31 Dec, 198.52%23.65%
30 Sep, 196.00%16.33%
30 Jun, 196.06%-

As of 30 Jun 24, Sonoma Pharmaceuticals is held by 2.79% institutional shareholders, representing a 122.92% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2410100.00%
31 Mar, 245-37.50%
31 Dec, 238300.00%
30 Sep, 232-33.33%
30 Jun, 233-57.14%
31 Mar, 237-12.50%
31 Dec, 228300.00%
30 Sep, 222-50.00%
30 Jun, 22433.33%
31 Mar, 223-25.00%
31 Dec, 214-42.86%
30 Sep, 21740.00%
30 Jun, 215-16.67%
31 Mar, 216200.00%
31 Dec, 202-77.78%
30 Sep, 209200.00%
30 Jun, 203-25.00%
31 Mar, 204-
31 Dec, 194100.00%
30 Sep, 192-80.00%
30 Jun, 1910-

10 institutional shareholders have increased their position in SNOA stock as of 30 Jun 24 compared to 5 in the previous quarter (a 100.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 242-
31 Mar, 242-
31 Dec, 232-50.00%
30 Sep, 23433.33%
30 Jun, 23350.00%
31 Mar, 232-33.33%
31 Dec, 223-
30 Sep, 22350.00%
30 Jun, 222-
31 Mar, 222-50.00%
31 Dec, 214300.00%
30 Sep, 211-80.00%
30 Jun, 215400.00%
31 Mar, 211-66.67%
31 Dec, 203200.00%
30 Sep, 201-50.00%
30 Jun, 202-
31 Mar, 202100.00%
31 Dec, 191-75.00%
30 Sep, 194-
30 Jun, 19--

2 institutional shareholders have reduced their position in SNOA stock as of 30 Jun 24 compared to 2 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 241721.43%434,996164.81%2.79%122.92%10100.00%2-
31 Mar, 2414-12.50%164,265-45.93%1.51%19.42%5-37.50%2-
31 Dec, 231633.33%303,776141.45%2.78%42.86%8300.00%2-50.00%
30 Sep, 2312-20.00%125,814-22.31%2.55%11.20%2-33.33%433.33%
30 Jun, 2315-11.76%161,94510.38%4.77%21.40%3-57.14%350.00%
31 Mar, 231730.77%146,7153.00%4.72%22.47%7-12.50%2-33.33%
31 Dec, 221344.44%142,440-20.26%4.58%13.82%8300.00%3-
30 Sep, 229-10.00%178,621-3.28%5.76%16.24%2-50.00%350.00%
30 Jun, 2210-184,6807.41%5.96%14.18%433.33%2-
31 Mar, 2210-9.09%171,945-3.02%6.48%19.56%3-25.00%2-50.00%
31 Dec, 2111-8.33%177,299-16.57%5.76%7.00%4-42.86%4300.00%
30 Sep, 2112-7.69%212,5040.20%9.07%8.83%740.00%1-80.00%
30 Jun, 21138.33%212,09019.76%10.13%12.87%5-16.67%5400.00%
31 Mar, 2112-177,098-2.21%8.87%11.39%6200.00%1-66.67%
31 Dec, 2012-7.69%181,097-7.65%8.83%9.25%2-77.78%3200.00%
30 Sep, 201362.50%196,10538.69%9.77%16.52%9200.00%1-50.00%
30 Jun, 208-11.11%141,39610.47%7.69%15.87%3-25.00%2-
31 Mar, 209-10.00%127,9970.16%6.96%9.59%4-2100.00%
31 Dec, 191011.11%127,78861.66%8.52%23.65%4100.00%1-75.00%
30 Sep, 199-10.00%79,047-0.92%6.00%16.33%2-80.00%4-
30 Jun, 1910-79,785-6.06%-10---

Sonoma Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 21, 2023Dal Poggetto Johnofficer ControllerSell5,000$1.15$5.75K-
Apr 13, 2023DVONCH JEROME Jofficer Interim CFOSell---31,009
Apr 13, 2023DVONCH JEROME Jofficer Interim CFOSell27,777$8.03$223.05K-
Apr 13, 2023DVONCH JEROME Jofficer Interim CFOSell30,000$4.60$138.00K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 21, 2024Trombly Amy Mossofficer Chief Executive OfficerA-AwardBuy53,586--153,586
Jun 21, 2024Thornton Bruceofficer Executive Vice PresidentA-AwardBuy53,586--154,411
Jun 21, 2024DVONCH JEROME Jofficer Chief Financial OfficerA-AwardBuy53,586--84,595
Jun 21, 2024Dal Poggetto Johnofficer ControllerA-AwardBuy15,000--15,000
Dec 29, 2023Trombly Amy Mossofficer Chief Executive OfficerA-AwardBuy60,000$0.18$10.80K173,648
Dec 29, 2023Thornton Bruceofficer Executive VP & COOA-AwardBuy60,000$0.18$10.80K176,781
Dec 29, 2023Dal Poggetto Johnofficer ControllerA-AwardBuy50,000$0.18$9.00K55,000
Dec 29, 2023DVONCH JEROME Jofficer Interim CFOA-AwardBuy60,000$0.18$10.80K117,777
Jul 21, 2023Dal Poggetto Johnofficer ControllerSell5,000$1.15$5.75K-
Jul 03, 2023Trombly Amy Mossofficer Chief Executive OfficerA-AwardBuy100,000--213,648
Jul 03, 2023Thornton Bruceofficer Executive Vice PresidentA-AwardBuy100,000--216,781
Apr 13, 2023DVONCH JEROME Jofficer Interim CFOSell---31,009
Apr 13, 2023DVONCH JEROME Jofficer Interim CFOSell27,777$8.03$223.05K-
Apr 13, 2023DVONCH JEROME Jofficer Interim CFOSell30,000$4.60$138.00K-
Dec 30, 2022White Chad Normanofficer Chief Financial OfficerA-AwardBuy9,753--14,753
Dec 30, 2022White Chad Normanofficer Chief Financial OfficerA-AwardBuy9,753$1.08$10.53K14,753
Dec 30, 2022Weigerstorfer Philippedirector-A-AwardBuy20,000--50,000
Dec 30, 2022Weigerstorfer Philippedirector-A-AwardBuy20,000$1.08$21.60K50,000
Dec 30, 2022Trombly Amy Mossofficer Chief Executive OfficerA-AwardBuy40,000--113,648
Dec 30, 2022Trombly Amy Mossofficer Chief Executive OfficerA-AwardBuy40,000$1.08$43.20K113,648

The last insider sell of Sonoma Pharmaceuticals's stock was made by Dal Poggetto John on Jul 21 2023, selling 5,000 shares at $1.15 per share (valued at $5.75K).

Sonoma Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20244--
Q4 20234--
Q3 2023-1-
Q2 20232366.67%
Q4 20221211200.00%
Q1 20226--
Q1 20213--
Q3 2020---
Q2 20202--
Q1 20201--
Q4 20192--
Q3 2019-3-
Q1 20192238.70%
Q4 2018---
Q3 201821200.00%
Q2 20183--
Q1 201814--
Q4 201711--
Q3 20177--
Q2 201712--

4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Sonoma Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q4 2023---
Q3 2023---
Q2 2023---
Q4 2022---
Q1 2022---
Q1 2021---
Q3 2020---
Q2 2020---
Q1 2020---
Q4 2019---
Q3 2019---
Q1 2019---
Q4 2018---
Q3 2018---
Q2 2018---
Q1 20185--
Q4 20177--
Q3 20173--
Q2 2017---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Sonoma Pharmaceuticals's stocks.

Sonoma Pharmaceuticals Peer Ownership


TickerCompany
AKANAkanda Corp.
TKNOAlpha Teknova, Inc.
ACORAcorda Therapeutics, Inc.
SBFMSunshine Biopharma, Inc.
LFCRLifecore Biomedical, Inc.
UPCUniverse Pharmaceuticals INC
GHSIGuardion Health Sciences, Inc.
ALIMAlimera Sciences, Inc.
SHPHShuttle Pharmaceuticals Holdings, Inc.
DERMJourney Medical Corporation
PTPIPetros Pharmaceuticals, Inc.
SXTCChina SXT Pharmaceuticals, Inc.

SNOA Ownership FAQ


Sonoma Pharmaceuticals is owned by institutional shareholders (2.79%), insiders (1.51%), and public (95.70%). The largest institutional shareholder of Sonoma Pharmaceuticals is GEODE CAPITAL MANAGEMENT, LLC (0.56% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.00% of total shares).

Sonoma Pharmaceuticals's major institutional shareholders are GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, HRT FINANCIAL LP, XTX TOPCO LTD, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 1.07% of the company's share outstanding.

As of Jun 2024, there are 17 institutional shareholders of Sonoma Pharmaceuticals.

GEODE CAPITAL MANAGEMENT, LLC owns 86.64K shares of Sonoma Pharmaceuticals, representing 0.56% of the company's total shares outstanding, valued at $18.38K (as of Jun 2024).

As of Jun 2024, STATE STREET CORP holds 24.32K shares of Sonoma Pharmaceuticals (SNOA), compromising 0.16% of the company, valued at $5.16M.

HRT FINANCIAL LP is the third largest holder of Sonoma Pharmaceuticals. The company owns 21.52K of the company's shares outstanding (worth $4K).